$45M iRhythm Technologies Securities Class Action Settlement
iRhythm Technologies has agreed to pay $45 million to settle a securities class action. If you purchased iRhythm Technologies (NASDAQ: IRTC) common stock during the class period, you may be entitled to a cash payment based on your recognized stock losses.
Do I Qualify?
You may be eligible if:
- Investors who purchased iRhythm Technologies (NASDAQ: IRTC) common stock during the class period
- You provide brokerage records showing purchase and sale dates and prices
- Check the official settlement page for the current filing deadline
Brokerage records are required. You must provide records showing your purchase dates, prices, and any sales during the class period.
Notify me when a settlement opens
We will email you the moment an official claim portal opens for this case.
What Happened?
iRhythm Technologies, the maker of the Zio cardiac monitor patch used by millions of patients to detect heart arrhythmias, was sued by shareholders who alleged the company made misleading statements about reimbursement rates from Medicare and the impact of CMS reimbursement cuts on its business. The lawsuit alleged that iRhythm executives concealed the severity of pending reimbursement reductions while continuing to project strong revenue growth.
When CMS announced significant cuts to reimbursement rates for iRhythm's core product, the company's stock price fell sharply, causing substantial losses for investors. iRhythm agreed to pay $45 million to settle the class action, with the majority of the settlement funded by the company's directors and officers insurance.
How Much Will I Actually Get?
Payments are calculated based on your recognized loss during the class period. Brokerage records showing purchase and sale dates and prices are required. Check the official settlement page for the current deadline and claim filing instructions.
Last reviewed: June 22, 2026 | SuitAlert will update this page when the claims portal opens.